Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 25, 2024
Safety and effectiveness of isavuconazole in real-life non-neutropenic patientsPatricia Monzó-Gallo, Carlos Lopera, Ana M Badía-Tejero, et al.
Critical Care (London, England)|March 29, 2020
Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohortsMatteo Bassetti, Antonio Vena, Marco Meroi, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2022
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort studyRosa Escudero-Sanchez, Alfonso Muriel García, Sergio García Fernández, et al.
Emerging Infectious Diseases|December 22, 2020
Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015Elena Pérez-Nadales, Ana Alastruey-Izquierdo, María José Linares-Sicilia, et al.
Medicina Clinica|December 19, 2002
[Retrospective epidemiological study on the durability of the treatment of HIV infection or AIDS in Spain]José Ramón Arribas López, Susana Sanz Baena, Susana Hernández Albujar, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|August 7, 2024
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendationsMario Fernández-Ruiz, Juan José Castón, José Luis Del Pozo, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infectious Diseases and Therapy|May 25, 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2019
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Pageof 16